Central stimulant prescribing for ADHD variable in WA

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.526, 2007-01, pp. : 9-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prescribing of central stimulants increasing in ADHD

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 351, 2002-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Central stimulant use in ADHD a burden in the US

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 436, 2003-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Lisdexamfetamine dimesylate: a new option in stimulant treatment for ADHD

By Dew Rachel E Kollins Scott H

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 17, 2010-12 ,pp. : 2907-2913

Informa Healthcare

Access to resources Recommend Favorite

Medicating Children: The Enduring Controversy over ADHD and Pediatric Stimulant Pharmacotherapy

Child and Adolescent Psychopharmacology News, Vol. 13, Iss. 5, 2008-10 ,pp. : 1-5

Guilford Publications Inc

Access to resources Recommend Favorite

The ADHD–Smoking Comorbidity and Implications for Stimulant Treatment in Children and Adolescents

Child and Adolescent Psychopharmacology News, Vol. 18, Iss. 6, 2013-12 ,pp. : 1-5

Guilford Publications Inc

Access to resources Recommend Favorite